MX2010001263A - Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion. - Google Patents

Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.

Info

Publication number
MX2010001263A
MX2010001263A MX2010001263A MX2010001263A MX2010001263A MX 2010001263 A MX2010001263 A MX 2010001263A MX 2010001263 A MX2010001263 A MX 2010001263A MX 2010001263 A MX2010001263 A MX 2010001263A MX 2010001263 A MX2010001263 A MX 2010001263A
Authority
MX
Mexico
Prior art keywords
injection
solution
kit preparation
acid amide
preparation
Prior art date
Application number
MX2010001263A
Other languages
English (en)
Inventor
Teruhisa Yoshizawa
Akiko Miyoshi
Masato Ota
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of MX2010001263A publication Critical patent/MX2010001263A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una inyección que comprende un antibiótico de antraciclina contra un tumor maligno y por lo menos una amida de ácido seleccionada del grupo que consiste de amida de ácido nicotínico, amida de ácido isonicotínico y etanolamida de ácido gentísico.
MX2010001263A 2007-09-04 2008-09-03 Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion. MX2010001263A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007228516 2007-09-04
PCT/JP2008/065865 WO2009031577A1 (ja) 2007-09-04 2008-09-03 注射剤、注射液および注射用キット製剤

Publications (1)

Publication Number Publication Date
MX2010001263A true MX2010001263A (es) 2010-10-04

Family

ID=40428891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001263A MX2010001263A (es) 2007-09-04 2008-09-03 Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.

Country Status (10)

Country Link
US (1) US8227430B2 (es)
EP (1) EP2184066B1 (es)
JP (1) JP4456177B2 (es)
KR (1) KR101511398B1 (es)
CN (1) CN101795694B (es)
BR (1) BRPI0816364B8 (es)
ES (1) ES2439497T3 (es)
HK (1) HK1142820A1 (es)
MX (1) MX2010001263A (es)
WO (1) WO2009031577A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN108159005B (zh) * 2012-04-09 2021-03-23 日本迈科洛生物制药有限公司 注射剂用组合物
JP7001454B2 (ja) 2017-12-18 2022-01-19 日本化薬株式会社 ホスアプレピタントを含有する医薬製剤
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB485569A (en) * 1936-11-17 1938-05-17 Ig Farbenindustrie Ag Process for the manufacture of stable solutions of the polyoxyalkylisoalloxazines
JPS58105917A (ja) 1981-12-21 1983-06-24 Toa Eiyou Kagaku Kogyo Kk イソソルビド硝酸エステル溶液
GB8426672D0 (en) 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
EP0438183B1 (en) * 1986-12-05 1995-11-08 PHARMACIA S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4875311A (en) * 1988-04-20 1989-10-24 Sun Room Designs, Inc. Beam construction
JP2919112B2 (ja) 1991-05-13 1999-07-12 武田薬品工業株式会社 セファロスポリン注射剤およびその製造法
JP2915252B2 (ja) 1993-06-30 1999-07-05 明治製菓株式会社 溶解性が改善された製剤の製造法
TW280770B (es) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
JPH09124503A (ja) 1995-10-27 1997-05-13 L T T Kenkyusho:Kk アミチアマイシン類の注射用の抗菌性組成物
JP2000212088A (ja) 1999-01-27 2000-08-02 Kobayashi Kako Kk 難溶性抗ウイルス剤の水溶液
KR100405161B1 (ko) 2000-12-14 2003-11-12 신풍제약주식회사 록소프로펜 함유 근육주사제 조성물
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
JP2003261449A (ja) 2002-03-05 2003-09-16 Nisshin Oillio Ltd ファモチジン含有水性注射剤およびその製造法
JP2004010479A (ja) * 2002-06-03 2004-01-15 Japan Science & Technology Corp ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法
JP2004051526A (ja) 2002-07-18 2004-02-19 Nippon Shokubai Co Ltd 多価フェノールの製造方法
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
HK1142820A1 (en) 2010-12-17
US20100173862A1 (en) 2010-07-08
BRPI0816364B8 (pt) 2021-05-25
WO2009031577A1 (ja) 2009-03-12
EP2184066A1 (en) 2010-05-12
JPWO2009031577A1 (ja) 2010-12-16
KR101511398B1 (ko) 2015-04-24
JP4456177B2 (ja) 2010-04-28
US8227430B2 (en) 2012-07-24
CN101795694A (zh) 2010-08-04
KR20100051694A (ko) 2010-05-17
EP2184066B1 (en) 2013-11-06
CN101795694B (zh) 2012-10-10
BRPI0816364A2 (pt) 2015-09-29
EP2184066A4 (en) 2012-08-01
BRPI0816364B1 (pt) 2020-10-13
ES2439497T3 (es) 2014-01-23

Similar Documents

Publication Publication Date Title
JO2778B1 (en) Certain vehicles, installations and methods
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2008094545A3 (en) Mic orna-based methods and compositions for the treatment of acute myeloid leukemia
WO2008046911A3 (en) Novel human micrornas associated with cancer
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
MX2010000465A (es) Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
TNSN07323A1 (en) Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors
EP2079500A4 (en) DEVICES AND METHODS FOR INFUSION
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
DK2092065T4 (da) Antisense-forbindelser
WO2007081740A3 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
WO2007134210A3 (en) Methods and compositions for the diagnosis and treatment of cancer
IN2009DN05670A (es)
MX2008001538A (es) Aril piridinas y metodos para su uso.
EP2101772A4 (en) NEUROMUSCULAR BLOCKAGE AGENTS WITH INTERMEDIATE DURATION AND THEIR ANTAGONISTS
WO2007097981A3 (en) Alpha carbolines and uses thereof
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
AU2010332955A8 (en) 3,4,4A,10B-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives
GB0522082D0 (en) Formulations
WO2009124653A3 (de) Thienopyrimidine
MY150643A (en) Methods and compositions for targeting hepsin
MX2010001263A (es) Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.
IL198465A0 (en) Triazabenzo[e]azulene derivatives for the treatment of tumors

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status